Related Organization(s)

You just read:

GB Sciences Completes Nanotechnology Transfer of Exclusively-Licensed, Cannabinoid-Based, Time-Released Neuropathic Pain Formula

News provided by

GB Sciences, Inc.

Apr 04, 2018, 05:30 ET